Lancet 1998 Jul 25
Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group.
Related Questions
New answer by Radiation Oncologist at Washington University School of Medicine (April 22, 2015)
I agree with @Roy H. Decker.While survival in resected lung cancer is dominently driven by nodal status, the utility of PORT is murky.The principal issue appears to be a trade...
Would adjuvant chemotherapy suffice, or would you also consider RT in a patient with a PS of 0-1? Would your recommendations change if it was N0...
New answer by Radiation Oncologist at University of Massachusetts Medical School (July 28, 2016)
At present, the role of post-operative radiotherapy (PORT) has been shown, but not definitely proven to be detrimental for patients with resected NSCLC with N0 and N1 involvem...
Conversely: In a patient with N2 EGFR+ NSCLC receiving radiation, would you still consider use of osimertinib?
New comment by Radiation Oncologist at Mon Health ( March 16, 2021)
Thank you. Stay safe, my friend.
-Fred
Do you routinely offer post-operative adjuvant radiation in addition to chemotherapy? Are the results of the recently published negative phase II...
New comment by Radiation Oncologist at Mary Bird Perkins Cancer Center ( August 24, 2022)
While what Dr. Cady said seems reasonable, it's an unproven hypothesis. It requires backing from randomized trials with a sufficient number of cohorts and adequate length of f...